Back on the growth track: a research report by Edison

22 Mar 2021

Throughout 2020, EMIS focused on helping its customer base in the fight against Covid-19, adapting its solutions to support testing and treatment of the disease and the vaccine roll-out programme.

Edison highlights that EMIS reported flat revenue and adjusted operating profit for the year and has indicated that it expects growth to resume in 2021.

Development of the EMIS-X platform, started in 2018, positions the company well to meet the evolving needs of the healthcare sector, opening up opportunities in health data analytics and collaboration between the health and life sciences sectors.

Read the full report.